In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
The closing price of Edgewise Therapeutics Inc (NASDAQ: EWTX) was $15.45 for the day, down -1.28% from the previous closing price of $15.65. In other words, the price has decreased by -$1.28 from its previous closing price. On the day, 0.53 million shares were traded. EWTX stock price reached its highest trading level at $16.05 during the session, while it also had its lowest trading level at $15.27.
Ratios:
Our analysis of EWTX’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 19.50 and its Current Ratio is at 19.50. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Piper Sandler on March 07, 2024, initiated with a Overweight rating and assigned the stock a target price of $48.
Goldman Downgraded its Neutral to Sell on August 25, 2022, while the target price for the stock was maintained at $5.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Feb 09 ’24 when MOORE JOHN R sold 8,029 shares for $20.01 per share. The transaction valued at 160,657 led to the insider holds 0 shares of the business.
Derakhshan Behrad sold 4,800 shares of EWTX for $96,209 on Feb 09 ’24. The Chief Business Officer now owns 7,020 shares after completing the transaction at $20.04 per share. On Feb 08 ’24, another insider, Derakhshan Behrad, who serves as the Chief Business Officer of the company, sold 4,600 shares for $20.01 each. As a result, the insider received 92,049 and left with 7,020 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, EWTX now has a Market Capitalization of 1438558720 and an Enterprise Value of 1125580160.
Stock Price History:
Over the past 52 weeks, EWTX has reached a high of $20.69, while it has fallen to a 52-week low of $5.12. The 50-Day Moving Average of the stock is -10.66%, while the 200-Day Moving Average is calculated to be 50.11%.
Shares Statistics:
EWTX traded an average of 942.54K shares per day over the past three months and 515610 shares per day over the past ten days. A total of 70.45M shares are outstanding, with a floating share count of 62.77M. Insiders hold about 32.59% of the company’s shares, while institutions hold 64.30% stake in the company. Shares short for EWTX as of 1711584000 were 5724282 with a Short Ratio of 6.07, compared to 1709164800 on 5461677. Therefore, it implies a Short% of Shares Outstanding of 5724282 and a Short% of Float of 10.35.
Earnings Estimates
The stock of Edgewise Therapeutics Inc (EWTX) is currently in the spotlight, with Entera Bio Ltd. analysts actively rating and assessing its market standing.The consensus estimate for the next quarter is $42.47, with high estimates of $15.45 and low estimates of $8.23.
Analysts are recommending an EPS of between $Healthcare and $Healthcare for the fiscal current year, implying an average EPS of $Healthcare.
